Skip to content

Sands Capital Alternatives, LLC 13F Holdings · Q2 2026

Sands Capital Alternatives, LLC reported 24 securities worth $613.55M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: ALMR (18.68%), NU (15.45%), KVYO (9.67%). Among its top 25 positions this quarter: 3 new, 10 added, 2 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1ALMRALAMAR BIOSCIENCES INC$114.6M18.68%4.2MNew
2NUNU HLDGS LTD$94.8M15.45%7.1MAdded
3KVYOKLAVIYO INC$59.3M9.67%3.9MAdded
4BBNXBETA BIONICS INC$58.1M9.47%3.7MHold
5SGPSPYGLASS PHARMA INC$55.7M9.07%2.5MHold
6IKTINHIBIKASE THERAPEUTICS INC$26.4M4.31%13.0MHold
7DASHDOORDASH INC$23.5M3.84%127,562Added
8CPNGCOUPANG INC$23.1M3.76%1.3MAdded
9DDOGDATADOG INC$21.1M3.43%80,851Trimmed
10BIOABIOAGE LABS INC$19.3M3.14%786,353Hold
11TXG10X GENOMICS INC$18.5M3.01%481,770Hold
12IOTSAMSARA INC$16.7M2.73%515,658Trimmed
13ODTXODYSSEY THERAPEUTICS INC$16.4M2.67%875,000New
14TOSTTOAST INC$10.2M1.65%364,879Added
15ABOSACUMEN PHARMACEUTICALS INC$9.9M1.62%3.7MHold
16TTANSERVICETITAN INC$7.7M1.25%108,545Added
17CBRSCEREBRAS SYSTEMS INC$7.3M1.18%32,825New
18SNOWSNOWFLAKE INC$6.2M1.02%24,498Added
19MNDYMONDAY COM LTD$5.9M0.97%81,982Added
20TARSTARSUS PHARMACEUTICALS INC$5.3M0.87%85,000Hold
21TSHATAYSHA GENE THERAPIES INC$4.9M0.80%724,873Hold
22CADLCANDEL THERAPEUTICS INC$4.2M0.68%405,837Hold
23ACRVACRIVON THERAPEUTICS INC$4.1M0.66%2.3MAdded
24FIGFIGMA INC$400,9650.07%22,165Added

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR